Showing results (741-750 of 7,002) with videos related to
Sort By:
Pageof 701
Current Medical Research and Opinion|January 6, 2006
Assessment of asthma control in a general population of asthmaticsMichael Lenoir, Alyssa Williamson, Richard H Stanford, et al.Current Medical Research and Opinion|January 6, 2006
Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitorsAshish V Joshi, Jennifer M Stephens, Vicki Munro, et al.Current Medical Research and Opinion|January 6, 2006
Inappropriate use of inhaled short acting beta-agonists and its association with patient health statusSong Hee Hong, Brittany H Sanders, Donna WestCurrent Medical Research and Opinion|January 6, 2006
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) studyAllan Gibofsky, William R Palmer, John A Goldman, et al.Current Medical Research and Opinion|January 6, 2006
Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infectionHany Aziz, Mohammed Shubair, Vincent A Debari, et al.Current Medical Research and Opinion|December 7, 2007
Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database studyPatrizia Berto, Franco Frati, Cristoforo Incorvaia, et al.Current Medical Research and Opinion|January 3, 2008
Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eyeF S Mah, T O'Brien, T Kim, et al.Current Medical Research and Opinion|January 10, 2008
Angiotensin blockade with eprosartan: vascular and functional implicationsC Venkata S RamCurrent Medical Research and Opinion|January 10, 2008
The SCORE model in the POWER study: an attempt to focus the limited resources for prevention on patients with greatest needGuy De BackerCurrent Medical Research and Opinion|January 10, 2008
Risk reduction by preventing stroke: need for blockade of angiotensin II and catecholamines?Heinz RuppPageof 701